Clene Inc (CLNN) Stock Analysis

Verdict: AVOID

Severe cash burn and ongoing dilution risk outweigh CNM-Au8 pipeline potential, presenting substantial risk of further equity loss.

Investment score: 24/100

Analysis as of 2026-09-17

Is Clene Inc stock worth reviewing? The TradeMates thesis

Clene Inc (CLNN) faces severe insolvency and dilution risks despite insider participation in a recent $4.0M capital raise. The model recommends AVOID for non-speculative capital.

7-factor investment score

Valuation: 10/100 (weight 20%)
Financial Health: 10/100 (weight 15%)
Technical Momentum: 30/100 (weight 15%)
Earnings Quality: 20/100 (weight 15%)
Insider Sentiment: 45/100 (weight 10%)
Analyst Consensus: 60/100 (weight 10%)
Risk-Adjusted Return: 15/100 (weight 15%)

Clene Inc opportunities and risks

What speaks for CLNN

Insider alignment through $4.0M capital injection at $3.28 per share

What speaks against CLNN

Imminent cash exhaustion and aggressive shareholder dilution

Peers and competitors

SER
XLO
PDSB
TVGN
TIL

Trailing-twelve-month ratios
Ticker	P/E	P/S	EV/EBITDA	Gross margin	Net margin	FCF yield
CLNN	n/a	260.1x	n/a	-110.2%	-20059.9%	-31.2%
SER	n/a	0.0x	n/a	0.0%	0.0%	-63.3%
XLO	n/a	0.9x	3.4x	99.5%	-34.1%	-103.5%
PDSB	n/a	0.0x	n/a	0.0%	0.0%	-34.4%
TVGN	n/a	0.0x	n/a	0.0%	0.0%	-37.1%
TIL	n/a	0.0x	n/a	0.0%	0.0%	-48.6%
Peer median	n/a	0.0x	n/a	0.0%	0.0%	-48.6%

Frequently asked questions about Clene Inc (CLNN)

Is CLNN stock a good investment?

The TradeMates model rates Clene Inc as AVOID with an investment score of 24/100. Clene Inc (CLNN) faces severe insolvency and dilution risks despite insider participation in a recent $4.0M capital raise. The model recommends AVOID for non-speculative capital. This is algorithmic model output, not personal investment advice.

Is CLNN stock a buy?

The TradeMates model verdict for CLNN is AVOID with an investment score of 24/100. Treat this as a model signal to review, not a personal buy recommendation.